Twitxy Saved

Adrienne Nedved

@ANNedved

Hematology Pharmacist: Lymphoma & Cell Therapy @MayoClinic | BCOP | PharmD, MPA @DrakeUniversity | PGY1 @NebraskaMed | PGY2 Oncology @BarnesJewish | TweetsMyOwn
Minnesota, USA Joined September 2019
163 Following 104 Followers 14 Posts

Latest posts 4

Adrienne Nedved @ANNedved
REALBiTE with epcor and glofi in LBCL presented by Taylor Brooks, MD at @ASH24. Highlights of data courtesy of Dr. Major! Thankful to have been a part of this representing @MayoCancerCare Rochester with @YucaiWangMD
Ajay Major, MD, MBA Verified account @majorajay Dec 7, 2024
REALBiTE RW BsAb (glofi & epco) outcomes #lymsm #ASH24:
- 208 pts, 18% HGBL, 30% ECOG 2-4
- 60% prior CAR, 49% relapse w/i 90d
- mPFS dismal at ~2 mos, mOS 7 mos, no diff glofi v epco
- pts w/ CR did have durable responses
1/
View quoted post on X
0 replies 3 reposts 10 likes 1.1K views View on X
Adrienne Nedved @ANNedved
If you are looking for some tips on how to use and adjust patients on tafa+len therapy, then see ⤵️ for our helpful guideline! @GregNowakowski @kmaddmd #tafasitamab #lenalidomide #dlbcl
This review provides a practical clinical guide for the management of patients with relapsed/refractory diffuse large B-cell #lymphoma treated with #tafasitamab + #lenalidomide in routine clinical practice. doi.org/10.1093/oncolo…
View quoted post on X